Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial

Li, XM; Li, WF; Lin, JT; Yan, HH; Tu, HY; Chen, HJ; Wang, BC; Wang, Z; Zhou, Q; Zhang, XC; Su, J; Chen, RL; Wu, YL; Yang, JJ

Yang, JJ (corresponding author), Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Canc Ctr, 106 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China.; Wu, YL; Yang, JJ (corresponding author), Guangdong Acad Med Sci, 106 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China.; Wu, YL (corresponding author), Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, 106 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China.

CLINICAL LUNG CANCER, 2021; 22 (2): 100

Abstract

We investigated the potential use of mutant TP53 in prediction and prognosis of patients with non-small cell lung cancer. We analyzed data obtained fr......

Full Text Link